NANOSCIENCE – THEORY TO APPLICATION

/ Home
/ SUBMISSION

/ The BJNANO
/ Diamond Open Access
/ Journal Statistics
/ Editorial Board
/ Community
/ Call for papers

/ Latest Articles
/ Most accessed
/ Thematic issues
/ Featured collections
/ Volumes
/ Authors

/ E-Alerts

/ BlueSky
/ LINKEDIN
/ Mastodon
/ RSS FEED

Empty search

Article Type

Publication Date Range

Search Tips

This search combines search strings from the content search (i.e. "Full Text", "Author", "Title", "Abstract", or "Keywords") with "Article Type" and "Publication Date Range" using the AND operator.

Search Examples

aromatic	the word “aromatic”
aromatic aldehyde	the word “aromatic” OR “aldehyde”
+aromatic +aldehyde	both words “aromatic” AND “aldehyde”
+aromatic -aldehyde	the word “aromatic” but NOT “aldehyde”
“aromatic aldehyde”	the exact phrase “aromatic aldehyde”
benz*	words which begin with “benz”, such as “benzene” or “benzyl”
benz*yl	words that begin with “benz” and end with “yl”, such as “benzyl” or “benzoyl”
benzyl~	words that are close to the word “benzyl”, such as “benzoyl” (i.e., fuzzy search)

BROWSE
Latest Articles
Most accessed
thematic issues
Featured Collections
volumes
authors

BROWSE

Latest Articles Most Accessed Thematic Issues Featured Collections Volumes Authors

Author

1 article(s) from Chawla, Ruchi

Breaking barriers: nanosystems to overcome solubility and permeability challenges of second-generation tyrosine kinase inhibitors

Bhagya Shree,
Abhishek Sharma,
Manish Kumar,
Ruchi Chawla and
Brahmeshwar Mishra

Beilstein J. Nanotechnol. 2026, 17, 1063–1086, doi:10.3762/bjnano.17.73

PDF

Figure 1: Mechanistic comparison of drug absorption: conventional versus nanoformulation approaches. Figure 1 was cre...

Jump to Figure 1

Figure 2: Systematic search methodology regarding nanotechnology-enabled second-generation TKIs.

Jump to Figure 2

Figure 3: Nanotechnology Platforms for Enhancing Solubility and Permeability of TKIs. Figure 3 was created in BioRend...

Jump to Figure 3

Figure 4: Bioavailability increase of nanoformulations when compared to the free drug.

Jump to Figure 4

Figure 5: QbD framework for pharmaceutical product development.

Jump to Figure 5

Figure 6: Design space optimisation via response surface methodology. Figure 6 was created in BioRender. Mishra, B. (...

Jump to Figure 6

Figure 7: Translational and regulatory challenges in nanoformulation development. Figure 7 was created in BioRender. ...

Jump to Figure 7

Album

Review

Published 10 Aug 2026

Full text

Other Beilstein-Institut Open Science Activities

/ Help / Support & Contact / E-Alerts / Privacy Policy / Terms & Conditions / Impressum